In May this year I attended the American Urology Association Annual Meeting in Boston, an event that draws the largest amount (gathering of 16 thousands) of urologists from around the world.
The meeting provided attendees with nearly a week of urology education, cutting-edge research findings, a view of the latest in medical technology and treatment options.
I obtained the knowledge of the most recent developments and techniques as well as established guidelines in urology to ensure the highest standards of patient care and safety.
A lot of interest was developed and paid during the conference to the Interstitial Cystitis/Bladder Pain Syndrome.On the conference it was emphasized that the treatment of IC/BPS is individualized;
the most effective approach for a particular patient is best determined by the individual clinician and patient.
The IC/BPS panel has developed a treatment algorithm which includes elements for a basic assessment as well as available first line through six-line treatments
based on the balance between potential benefits to the patient and potential severity of adverse events.
This meeting gave me the opportunity to connect with leading specialists of Interstitial Cystitis – old and new. I had a chance to meet and discuss our project with the leading specialists in Interstitial Cystitis and Bladder pain syndrome.
Dr. Antonina Volikova